Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Nature-based Outdoor Activities for Promoting Stress Resilience in Employees

15 maggio 2026 aggiornato da: EUN YEONG CHOE, The Chinese University of Hong Kong, Shenzhen

The goal of this randomized controlled trial (RCT) is to assess the impact of a nature-based workplace intervention on stress resilience in full-time employees in Hong Kong.

The main question it aims to answer is: Does a nature-based group activity intervention improve stress resilience in employees?

Researchers will compare the intervention group (participants who attend three nature-based group sessions) to the control group (participants who receive no intervention and continue their usual routines) to see if the nature-based activities lead to greater improvements in stress resilience compared to no intervention.

Participants will complete baseline measurements (questionnaires, blood pressure, and heart rate variability) one week before the first session.

If assigned to the intervention group: Attend three one-hour group sessions at a nearby park (once every two weeks, 8:00-9:00 AM) involving mindful walking, gentle movement, nature observation, breathing exercises, and group reflection

If assigned to the control group: Continue their usual daily routines with no specific activities

Complete follow-up assessments (same measurements as baseline): immediately after the second session and one week after the third session

Primary measurement: HRV Secondary measurements: Blood pressure, Perceived stress scale (PSS) and the Difficulties in emotion regulation scale (DERS).

Panoramica dello studio

Stato

Completato

Condizioni

Descrizione dettagliata

Participants:

The participants of this study will be recruited from full-time employees at diverse corporate settings in Hong Kong. The sample size was determined using G*Power software. With a medium effect size (f = 0.25), an alpha level of 0.05, a desired power of 0.80, and a correlation among repeated measures of 0.50, the required total sample size was calculated to be 34. Accounting for an anticipated 20% attrition rate, the investigator aims to recruit 43 participants.

Study procedure:

This study uses a randomized controlled trial (RCT) to assess the impact of the workplace intervention on stress resilience in employees. To ensure allocation concealment, randomization will be performed by a third party (a program instructor who was not involved in participant recruitment or outcome assessment). Participants and researchers will be blinded to group assignment. The experimental procedure will be explained to potential participants in a recruitment poster, which required them to send their informed consent before participating. All participants will be invited to complete baseline measurements one week before the start of the first intervention session. Baseline measurements will take approximately 15-20 mins. Once the participants complete the questionnaire, the investigator will ask them to measure BP and HRV. All measurements will be taken after a 5-minute rest period in a seated position with back support, feet flat on the floor, and no talking. Participants will complete follow-up assessments at three time points using the same measures as at baseline (T1): T2 (immediately after the second session) and T3 (one week after the third session).

Tipo di studio

Interventistico

Iscrizione (Effettivo)

160

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Kowloon
      • Hong Kong, Kowloon, Hong Kong
        • The Hong Kong Polytechnic University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Descrizione

Inclusion Criteria:

  • Over 18 years
  • Full-time employees

Exclusion Criteria:

  • part-time employees
  • individuals employed for less than six months
  • those with symptoms of heart disease
  • participants over 65 years of age

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Outdoor activity group
Three days outdoor activity group
After randomization, participants in the intervention group will attend three group activity sessions, while those in the control group will receive no intervention and were instructed to continue their usual daily routines. The group activity sessions will be conducted at a nearby park for one hour each session (8:00-9:00 AM). Sessions will be held once every two weeks, for a total of three sessions. Each session will be contained various group activities, such as mindful walking, gentle movement, nature observation, breathing exercises and group reflection. These group activities led by facilitators aims to increase social interaction and nature exposure. Participants in the control group were not asked to attend specific activities.
Nessun intervento: No-treatment control group
No specific activities required

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Heart rate variability (HRV)
Lasso di tempo: From enrollment to the end of treatment at 8 weeks
HRV will be measured using SA-3000P (MEDICORE, Korea). The sensor is positioned with a strap around the fingertip of the middle finger on one of the participants hands. This study will use RMSSD (ms), SDNN (ms) and LF/HF ratio as HRV indicators to evaluate the stress response. In HRV analysis, higher RMSSD values indicate greater parasympathetic activity, reflecting relaxation and recovery. Similarly, Higher SDNN values indicate greater overall HRV, reflecting better autonomic nervous system flexibility. In contrast, higher LF/HF ratio values indicate sympathetic dominance, reflecting stress and arousal. This will be measured three times: at baseline (T1), immediately after the second session (T2), and one week after the third session (T3).
From enrollment to the end of treatment at 8 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Blood pressure (BP)
Lasso di tempo: From enrollment to the end of treatment at 8 weeks
BP will be measured using a digital automatic BP monitor (PASESA AVE-2000, Japan) with an arm cuff placed on the non-dominant arm at heart level. Normal systolic blood pressure (SBP) is defined as 120-139 mmHg, and normal diastolic blood pressure (DBP) as 80-89 mmHg. The incidence of elevated BP (SBP ≥140 mmHg or DBP ≥90 mmHg) in follow-up, rather than the diagnosis of hypertension, will be used as an outcome indicator of changes in stress levels. This will be measured three times: at baseline (T1), immediately after the second session (T2), and one week after the third session (T3).
From enrollment to the end of treatment at 8 weeks
Perceived stress scale (PSS)
Lasso di tempo: From enrollment to the end of treatment at 8 weeks
PSS measures the degree to which individuals perceive their lives as stressful. A total of 14 items (e.g., 'In the last three months, how often have you been upset because of something that happened unexpectedly? '), each of which uses a Likert scale ranging from 1 (never) to 5 (very often), are rated by participants. Higher score indicates higher stress levels. This will be measured three times: at baseline (T1), immediately after the second session (T2), and one week after the third session (T3).
From enrollment to the end of treatment at 8 weeks
Difficulties in emotion regulation scale (DERS)
Lasso di tempo: From enrollment to the end of treatment at 8 weeks
DERS assesses emotion regulation problems. A total of 18 items (e.g., 'I have difficulty making sense out of my feelings') are rated by participants using a Likert scale ranging from 1 (almost never) to 5 (almost always). Higher scores indicate greater emotion regulation difficulties. This will be measured three times: at baseline (T1), immediately after the second session (T2), and one week after the third session (T3).
From enrollment to the end of treatment at 8 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Eun Yeong Choe, PhD, The Chinese University of Hong Kong, Shenzhen

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

30 settembre 2025

Completamento primario (Effettivo)

30 ottobre 2025

Completamento dello studio (Effettivo)

30 marzo 2026

Date di iscrizione allo studio

Primo inviato

8 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

15 maggio 2026

Primo Inserito (Effettivo)

22 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

15 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • CUHKShenzhen_2

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Stress (Psicologia)

Prove cliniche su Nature outdoor activities

Sottoscrivi